We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Latest News

News

Polyplus-transfection Unveils Technology to Improve Intracellular Delivery of Small Interfering RNAs In-vivo

The "Sticky siRNA" technology is already being tested in vivo by academic laboratories and biotech companies.
News

Arrowhead Nanobiotechnology Subisidaries, Calando and Insert Complete Merger

The merger is part of a streamlining of the two companies in which Arrowhead assumed active management to focus resources on bringing multiple products to the clinic as rapidly.
News

VistaGen Collaborates with Canadian, U.S., and British Researchers to Isolate Embryonic Stem Cell-Derived Human Cardiac Cell

Researchers used embryonic stem cells differentiation cultures to successfully identify, grow and study the earliest cell destined to form the human heart.
News

Metabasis Therapeutics Extends Collaboration with Merck to Develop AMPK Activators for Diabetes and Other Metabolic Diseases

The two companies will continue their joint efforts to identify small molecule therapeutics with the potential to treat type 2 diabetes and other metabolic diseases.
News

Med BioGene and University Health Network Collaborate to Commercialize Critical Lung Cancer Prognostic Test

The collaboration provides MBI with exclusive, world-wide rights to develop and commercialize a critical prognostic test for early stage non-small-cell lung cancer developed by UHN.
News

Cytheris Announces Phase I Study of Interleukin-7 as Immunotherapy in Treatment of Immunodeficient Transplant Recipients

Clinical trial is designed to investigate use of IL-7 in treatment of patients who are vulnerable to a variety of bacterial, viral, and fungal infections.
News

BIOMAX INFORMATICS Selected as a Consortium Partner in the Newly Formed Center for Personalized Cancer Medicine

The company has been selected as a consortium partner in the OncoTyrol project Center for Personalized Cancer Medicine, an Austrian COMET-program.
News

Abraxis BioScience Reports Promising Clinical Data in Advanced Pancreatic Cancer Using a Combination of ABRAXANE® and Gemzar®

According to Company, drug combination shows clinical benefit in more than 70% of patients.
News

An award for young scientists in a young discipline

At the Conference for Systems Biology of Mammalian Cells (SBMC) in Dresden, Germany, outstanding dissertations will be honored with the MTZ®- Award for medical Systems Biology.
News

New Fragment-based Drug Discovery Platform Announced between IOTA and Beactica

Both companies will join forces to deploy a proprietary FBDD-based lead discovery and optimization platform.
Advertisement